Purchase Order 75D30122P14670
Award Date 8/2/22
Potential Completion Date 9/30/22
Potential Value $206K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, with a potential value of $159,999.10. The contract has a completion date of September 14, 2023 and was awarded on September 15, 2022. Illumina has previously received federal contract awards from agencies such as the NIH, USDA, and VA to provide a range of sequencing systems, reagents, and...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of a NextSeq sequencing system and has a ceiling value of $230,845.58. The contract has a period of performance ending on September 30, 2024. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Blanket Purchase Agreement (BPA) call to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions, to provide a NOVASEQ 6000 SEQUENCING SYSTEM. The firm fixed-price contract, valued at $875,000.00, was awarded on August 29, 2019 with a completion date of October 30, 2019. Illumina has a history of providing various sequencing instruments, reagents, and services to support...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a 5-year, Firm Fixed Price purchase order valued at $211,080.73 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The award is for maintenance services to support Illumina's sequencing platforms, such as NextSeq, NovaSeq, MiSeq, and iSeq, which are used across federal agencies including the NIH, CDC, USDA, and VA for research and diagnostics...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $54,367.08 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the repair/replacement and advanced support plan for ISEQ equipment, with performance to be completed by August 20, 2028. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and...
- The Department of Health and Human Services Food and Drug Administration awarded a $457,531.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of an ILLUMINA NEXTSEQ 2000 SEQUENCING SYSTEM, plus a preventative maintenance agreement, to be performed in Silver Spring, Maryland. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems and related...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Illumina, Inc. for the purchase of an ILLUMINA NEXTSEQ2000 SEQUENCING SYSTEM. The $236,845.00 firm fixed price contract has a completion date of November 2, 2020. Illumina is a manufacturer of genetic and genomic analysis solutions, and has previously provided sequencing instruments, reagents, and services to support...